Comparison of effectiveness of metacognitive and existential therapy on resilience, life expectancy and self-care behaviors in women with type II diabetes

Type 2 diabetes is a chronic and debilitating disease. Although the effectiveness of metacognitive and existential therapies on the psychological factors associated with this disease has been investigated, little attention has been paid to comparing the two methods. Therefore, the aim of this study was to comparison of effectiveness of metacognitive and existential therapies on resilience, life expectancy and self-care behaviors in women with type II diabets.

The research method was semi-experimental with pre-test and post-test design with control group. The statistical population included all women with type II diabetes who referred to Fazl Ibn Shazan Diabetes Center in Neyshabur in the second half of 2019 year. Sixty people were selected by convenience sampling method and randomly assigned to experimental and control groups. Participants answered the Connor and Davidson Resilience Scale (CD-RISC), Snyder Hope Scale (SHS), and The Summary of Diabetes Self-Care Activities (SDSCA). Multivariate analysis of covariance was used to analyze the data.

The results showed that there is no difference between metacognitive and existential therapies in increasing the resilience and life expectancy of patients with type II diabetes (p>0.05), but existential therapy is more effective in increasing self-care behaviors (p<0.01).

Metacognitive and existential therapies play an important role in increasing the resilience and life expectancy and even self-care behaviors of patients with type II diabetes, so these methods can be used alongside medical therapies.